Status | Study |
Not yet recruiting |
Study Name: Study of a Tetravalent Dengue Vaccine Administered Concomitantly or Sequentially With Adacel® in Healthy Subjects Condition: Dengue Fever Dengue Hemorrhagic Fever Date: 2016-12-12 Interventions: Biological: CYD Dengue Vaccine |
Enrolling by invitation |
Study Name: Cohort Event Monitoring for Dengvaxia®, CYD-TDV Dengue Vaccine Condition: Dengue Fever Dengue Hemorrhagic Fever Date: 2016-10-27 |
Recruiting |
Study Name: Immunogenicity and Safety of a Tetravalent Dengue Vaccine Booster Injection in Subjects Who Previously Completed a 3-dose Schedule Condition: Dengue Fever Dengue Hemorrhagic Fever Date: 2016-07-01 Interventions: Biological: CYD Dengue Vaccine (5 dose formulation) |
Active, not recruiting |
Study Name: Association of Host Genetics With Vaccine Efficacy and Study of Immune Correlates of Risk From a Tetravalent Dengue Vaccine Condition: Dengue Fever Dengue Haemorrhagic Fever Date: 2016-06-29 |
Active, not recruiting |
Study Name: Immunogenicity and Safety of 3-Dose and Booster Dose of Tetravalent Dengue Vaccine in Healthy Subjects 9 to 50 Years of Age Condition: Dengue Fever Dengue Hemorrhagic Fever Date: 2015-12-09 Interventions: Biological: CYD Dengue Vaccine |
Active, not recruiting |
Study Name: Study of a Booster Dose of a Tetravalent Dengue Vaccine in Subjects Who Previously Completed the 3-dose Schedule Condition: Dengue Fever Dengue Hemorrhagic Fever Date: 2015-12-03 Interventions: Biological: CYD Dengue Vaccine (5-dose formulation) |
Completed |
Study Name: Long-Term Study of Hospitalized Dengue & Safety in Thai Children Included in a Tetravalent Dengue Vaccine Efficacy Study Condition: Dengue Dengue Fever Dengue Hemorrhag Date: 2013-11-06 |
Completed |
Study Name: Activated Recombinant Human Factor VII in Patients With Dengue Haemorrhagic Fever Condition: Acquired Bleeding Disorder Dengue Haemorrhagic Fever Date: 2012-05-14 Interventions: Drug: activated recombinant human factor VII |
Completed |
Study Name: Study of a Tetravalent Dengue Vaccine in Healthy Adult Subjects Aged 18 to 45 Years in India Condition: Dengue Dengue Fever Dengue Hemorrhag Date: 2012-03-07 Interventions: Biological: Live, attenuated, recombinant dengue serotype 1, 2, 3, 4 virus |
Completed |
Study Name: Prospective Dengue Seroprevalence Study in 5 to 10 Year-old Children Condition: Dengue Dengue Fever Dengue Hemorrhag Date: 2011-11-18 |